Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
Yuying Zhang, Laboratory Medicine and Pathobiology PhD Candidate at University of Toronto, shared on LinkedIn:
”I am very grateful to have given my first conference oral presentation at the 2026 Canadian Society for Transfusion Medicine Annual Conference in Hamilton.
I presented one of my PhD research project on targeting human CD44 as a potential plasma-independent alternative to IVIg in immune thrombocytopenia.
This was a meaningful milestone for me as my first oral presentation at a conference.
I really appreciated the opportunity to share my work, receive thoughtful questions, and connect with the transfusion medicine community.
A huge thank you to my supervisor Dr. Alan H. Lazarus, my mentor Alequis Pavon Oro, my supportive lab members, the vivarium staff, the research core facilities at the Keenan Research Centre for Biomedical Science and my thesis advisory committee members.
I am also grateful to Canadian Blood Services, Mitacs, the UofT Department of Laboratory Medicine & Pathobiology for their support.
Excited to keep learning, improving, and moving forward.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?